tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily

Soleno Therapeutics (SLNO) Financial Statements

711 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.314; its P/E ratio is -17.86; Soleno Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -76.62M$ -21.85M$ -21.00M$ -9.36M$ -8.47M
EBITDA$ -76.12M$ -20.89M$ -20.98M$ -8.87M$ -7.99M
Net Income Common Stockholders$ -76.62M$ -21.85M$ -21.40M$ -10.86M$ -8.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 256.78M$ 266.12M$ 149.63M$ 52.44M$ 19.37M
Total Assets$ 296.71M$ 304.13M$ 168.84M$ 63.55M$ 30.94M
Total Debt$ 3.03M$ 296.00K$ 347.00K$ 470.00K$ 485.00K
Net Debt$ -253.75M$ -265.83M$ -149.28M$ -51.97M$ -18.88M
Total Liabilities$ 32.01M$ 22.74M$ 25.45M$ 40.33M$ 18.52M
Stockholders Equity$ 264.70M$ 281.39M$ 143.39M$ 23.22M$ 12.43M
Cash Flow-
Free Cash Flow$ -15.09M$ -17.71M$ -12.51M$ -6.33M$ -5.57M
Operating Cash Flow$ -14.90M$ -17.70M$ -12.50M$ -6.33M$ -5.57M
Investing Cash Flow$ 4.04M$ -120.92M$ -115.24M--
Financing Cash Flow$ 2.27M$ 152.75M$ 938.00K$ 39.40M$ 17.06M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis